Expression of the protein arginine methyltransferase (PRMT) 1 is increased in AML blasts and it was demonstrated that in FLT3 ITD+ AML blasts, FLT3 is the major target of PRMT1. This evidence concerns the gene PRMT1 and acute myeloid leukemia.